| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vivos Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 181K | $477K | $2.64 | Nov 26, 2024 | Direct |
| Vivos Therapeutics, Inc. | Chief Financial Officer | Common Stock | 80 | $42.40 | $0.53 | Nov 26, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| VVOS | Vivos Therapeutics, Inc. | Nov 26, 2024 | 1 | $395K | 4 | Nov 27, 2024 | Chief Financial Officer |
| VVOS | Vivos Therapeutics, Inc. | Jun 20, 2024 | 1 | $35.7K | 4 | Jun 28, 2024 | Chief Financial Officer |
| VVOS | Vivos Therapeutics, Inc. | Dec 23, 2022 | 1 | $96K | 4 | Dec 28, 2022 | Chief Financial Officer |
| VVOS | Vivos Therapeutics, Inc. | Feb 25, 2022 | 1 | $164K | 4 | Feb 28, 2022 | Chief Financial Officer |
| VVOS | Vivos Therapeutics, Inc. | Aug 31, 2021 | 4 | $1.76M | 4 | Sep 2, 2021 | Chief Financial Officer |
| VVOS | Vivos Therapeutics, Inc. | May 25, 2021 | 1 | $5.29K | 4 | May 25, 2021 | Chief Financial Officer |